Results 141 to 150 of about 36,968 (256)

Improved bilirubin reduction with therapeutic plasma exchange and haemoperfusion in a dog with immune‐mediated haemolytic anaemia

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract A 6‐year‐old spayed female Golden Retriever mix was diagnosed with immune‐mediated haemolytic anaemia. Initial treatments included immunosuppression and blood transfusions. With acute mentation decline and rapid increase in serum bilirubin, therapeutic plasma exchange (TPE) was initiated.
Natasha S. Yeh   +2 more
wiley   +1 more source

Plasma Dilution After Myocardial Ischemia–Reperfusion Injury Promotes Cardiac Repair, Heart Performance, and Recovery of Motor Function and Endurance in Old Mice

open access: yesAging Cell, Volume 25, Issue 5, May 2026.
Plasma dilution at 24 h after I/R improved cardiac remodeling, function, and the physical performance of old male and female mice, through lowered markers of inflammation, fibrosis, reduction of cardiomyocytes' apoptosis, increase in their cell‐cycle re‐entry, and healthier profile of newly synthesized proteome, including the determinants of Jak/Stat ...
Joana Marie C. Cruz   +11 more
wiley   +1 more source

Coordinating a bi‐level blood supply chain with interactions between supply‐side and demand‐side operational decisions

open access: yesInternational Transactions in Operational Research, Volume 33, Issue 3, Page 1971-2015, May 2026.
Abstract In most blood supply chains, blood centers and hospitals make individual decisions, resulting in an inefficient structure of the blood supply chain, which in turn renders supply and demand matching a challenging exercise. In this work, we make the very first attempt to optimize the interaction between blood centers and hospitals.
Mohammad S. Moshtagh   +2 more
wiley   +1 more source

Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients. [PDF]

open access: yesTransfusion
Röhnert MA   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy